VCEL

Vericel Corporation

Price

$43.57

return (12m)

20.46%

p/e

93.09

p/bv

6.09

DIVIDEND YIELD

0.00%

VCEL price

Vericel

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VCEL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.60%

3 months

23.95%

1 year

20.46%

2 years

-7.92%

5 years

-17.03%

10 years

1,819.38%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VCEL

Valuation

P/E

93.09

Sector -4.38

Industry -4.38

P/BV

6.09

Sector 2.02

Industry 2.02

P/Revenue (PSR)

7.36

Sector -4.40

Industry -4.40

EV/EBITDA

882.81

Sector -263.09

Industry -263.09

EV/EBIT

882.81

Sector -702.90

Industry -702.90

P/EBITDA

70.99

Sector -4.39

Industry -4.39

P/EBIT

87.66

Sector -4.73

Industry -4.73

P/Total Assets

4.48

Sector 1.49

Industry 1.49

P/Net Current Assets

17.09

Sector -11.70

Industry -11.70

P/Working Capital

10.63

Sector -3.19

Industry -3.19

EPS

0.47

Sector -2.14

Industry -2.14

BVPS

7.26

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

74.56%

Sector 36.74%

Industry 36.74%

EBITDA Margin

3.06%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

3.06%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

5.95%

Sector -38.22%

Industry -38.22%

Net Profit Margins

7.91%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.15

Sector 0.03

Industry 0.03

Profitability

ROE

6.55%

Sector -65.14%

Industry -65.14%

ROA

4.82%

Sector -65.53%

Industry -65.53%

ROIC

0.57%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.04

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-68.55

Sector -6.07

Industry -6.07

Net Debt / EBIT

-68.55

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.44

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.74

Sector 0.41

Industry 0.41

Liabilities/Assets

0.26

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

14.42%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Vericel ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$43.57

Fair Value

$8.76

Upside Return potential.

-79.89%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VCEL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VCEL Vericel Corporation	$43.57	19.96%	0.00%	93.09	6.09	6.55%	7.91%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VCEL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vericel

Vericel Corporation

Average Investor10 user rating

4.0 (0 people)

United States

37 years

Founded: 1989

1997

Time since IPO - 29 years

241

Employees

Vericel Corporation (United States) is listed on the Nasdaq and has a market capitalization of $2.25 billion, with shareholders equity totaling $370.04 million.

The company employs approximately 241 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vericel Corporation reported $306.30 million in revenue, generating net income of $24.22 million.

Key financial metrics include a P/E ratio of 93.09, a price-to-book (P/B) ratio of 6.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VCEL.

Market cap

$2.25 billion

Net worth

$370.04 million

$370,040,000.00

Assets

$502.87 million

$502,870,000.00

Total Shares Outstanding

51.00 million

51,000,000

Average Daily Trading Volume

$583.33 Thousand

$583,328.00

Sector

Health Care

Industry

Biotechnology

VCEL

VCEL revenue and profits

Financial Results VCEL

DRAG THE FRAME TO SEE MORE DATA

VCEL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Vericel (VCEL) today?

A cotação de Vericel (VCEL) hoje está em US$ 43.57, com uma variação de 20.46% em relação ao último ano. A cotação de Vericel (VCEL) iniciou o ano negociando na casa dos US$ 36.01 e hoje está em US$ 43.57. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Vericel (VCEL) e dados de ações do Ibovespa e mercados internacionais.

Quando Vericel (VCEL) paga dividendos?

Vericel (VCEL) não distribuiu dividendos no último ano.

Is Vericel (VCEL) a good investment?

Atualmente, Vericel (VCEL) está cotada a US$ 43.57, com um P/L de 93.09, representando um desvio de -2,841% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 20.46 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 20.46%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vericel (VCEL) stock?

Investir em ações de Vericel (VCEL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Vericel (VCEL) yield today?

A rentabilidade de Vericel (VCEL) foi de -4.60% no último mês, 20.46% no último ano e -17.03% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Vericel (VCEL) hoje, o investimento total seria de US$ 4,357.00, com base na cotação atual de US$ 43.57.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,248.44
Em 5 anos: US$ 3,615.00
Em 10 anos: US$ 83,627.39

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VCEL

Vericel Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VCEL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING VCEL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vericel

Vericel Corporation

United States

37 years

1997

241

PROFIT X PRICE VCEL

Financial Results VCEL

VCEL cash flow

Asset, Revenue and Profit Growth - VCEL

VCEL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions